Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: DUOPROSS MEDITECH CORPORATION
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2020-08-03 to 2021-10-31
Current total value of award: $47702256.24
Description: COVID-19 ACTION  MODIFICATION TO DE-OB REMAINING FUNDS WITH THE EXCEPTION OF RE-OBLIGATION TO CLIN 0016 TO FUND OUTSTANDING BALANCE OWED TO THE CONTRACTOR. CLIN 0016 DELIVERY DATE ESTABLISHED DUE TO DFAS REQUIREMENT. CONTRACT IS NOT EXTENDED.